Table 6.
Vaccine type (dose) | Chronic disease |
---|---|
MenACWY (1 dose) | Non-malignant haematological disorders |
Pneumococcal vaccine (PCV; PPV after at least 12 months) | Non-malignant haematological disorders |
Chronic cardiac disease | |
Chronic pulmonary disease | |
Diabetes | |
Patients who have or are candidates for cochlear implants | |
Patients with chronic cerebrospinal fluid leaks due to trauma or surgical intervention | |
Cystic fibrosis | |
Hib (1 dose, if not previously vaccinated) | Patients who have or are candidates for cochlear implants |
Influenza vaccine (seasonal) | Haematological diseases (not cancer) |
Chronic cardiac and/or pulmonary disease | |
Diabetes | |
Cystic fibrosis |
MenACWY meningococcal conjugate vaccine (quadrivalent), PCV pneumococcal conjugate vaccine, PPV pneumococcal polysaccharide vaccine, Hib H. influenzae type b vaccine